Joslin Diabetes Center researchers are making discoveries that improve diabetes care and move us closer to a cure. Read ...

The Bioinformatics and Biostatistics Core at Joslin Diabetes Center offers support for data-driven projects related to basic, clinical, and translational research, with a particular emphasis on ...

A Multi-Center Clinical Trial of Allopurinol to Prevent Renal Function (GFR) Loss in Type 1 Diabetes The purpose of this study is to find out whether a medication called allopurinol can prevent kidney ...

Nicole Patience, MS, RDN, LDN, CDCES, CEDRD, is a nutrition and diabetes educator as well as an eating disorders specialist at Joslin Diabetes Center. Ms. Patience's clinical interests include Young ...

Classes will be conducted virtually via the Zoom meeting platform. 2 Early Education and Care (EEC) contact hour certificates will be provided. Upon completion of this class, the participant will be ...

The objective of the Molecular Phenotyping and Genotyping Core is to support Joslin and external investigators in the study of molecular mechanisms of disease by providing equipment, expertise, and ...

Tissue morphology and knowledge of the localization of specific proteins within a cell are integral to understanding cellular metabolism, the causes and consequences of diabetes, and new advances for ...

Louise Ambler-Osborn, MS, PNP, is a Pediatric Nurse Practitioner at Joslin Diabetes Center. Ms. Ambler-Osborn's special interests include outdoor education and exercise management with diabetes.

If you’re a parent or another caregiver for a child with diabetes, there’s a lot to know. It can be overwhelming. At Joslin Diabetes Center, we’re here for you and your whole family. It’s our goal to ...

Dr. Lyle Mitzner is an endocrinologist in Joslin's Adult Clinic. He received his medical degree from Albert Einstein College of Medicine and has been in practice for more than 20 years.

Fioralda Kico is a Nurse Practitioner at the Joslin Diabetes Center.

Boston, MA – Investigators at Joslin Diabetes Center have conducted the first comprehensive clinical characterization of cognitive decline in people with long-duration type 1 diabetes (T1D). Published ...